High-flow Hemofiltration as an Adjunctive Therapy in Sepsis

  • P. M. Honoré
  • O. Joannes-Boyau
  • W. Boer


Almost ten years ago, standard hemofiltration was often provided at 1 or 2 l/h of ultrafiltration and only in pre-dilution mode. However, practice began to change as results from new studies were published in the early 2000s demonstrating a beneficial effect on outcome of increasing the ultrafiltration rate to 35 ml/kg/h in patients with acute kidney injury (AKI). Two methods of high volume hemofiltration (HVHF), with different underlying concepts and results, became prevalent: Continuous high volume hemofiltration (CHVH) providing 50 to 70 ml/kg/h 24 hours a day, and intermittent high volume hemofiltration (IHVH) with brief, very high volume treatment at 100 to 120 ml/kg/h for 4 to 8 hours (previously called ‘pulse’ HVHF). Two recently published studies [1, 2] highlight the crucial role of adequate dosage of continuous venovenous hemofiltration (CVVH), demonstrating that, in critically ill patients with renal failure, a dose of 35 ml/kg/hour was associated with dramatic improvement in survival of nearly 20 %. The incorporation of the results from these studies into daily clinical practice can now be deemed to be urgent, although the results of other ongoing confirmatory (or not) studies are awaited. In a world increasingly guided by evidence based medicine, two level I studies lead to a Grade A recommendation, and this intervention should, therefore, be applied by every intensivist instigating continuous hemofiltration, while awaiting the results of the ongoing studies. Nevertheless, the implementation process is exposed to a number of potential difficulties.


Septic Shock Renal Replacement Therapy Acute Kidney Injury Systemic Inflammatory Response Syndrome Septic Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ronco C, Bellomo R, Homel P, et al (2000) Effects of different doses in continuous venovenous haemofiltration. Lancet 356: 26–30CrossRefPubMedGoogle Scholar
  2. 2.
    Saudan P, Niederberger M, De Seigneux S, et al (2006) Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70: 1312–1317CrossRefPubMedGoogle Scholar
  3. 3.
    Metnitz PG, Krenn CG, Steltzer H, et al (2002) Effects of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30: 2051–2058CrossRefPubMedGoogle Scholar
  4. 4.
    Mehta RL, McDonald B, Gabbai FB, et al (2001) Collaborative Group for treatment of ARF in the ICU. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60: 1154–1163CrossRefPubMedGoogle Scholar
  5. 5.
    Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348: 138–150CrossRefPubMedGoogle Scholar
  6. 6.
    Ronco C, Bellomo R (2002) Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 25: 733–747PubMedGoogle Scholar
  7. 7.
    Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bellomo R (2003) Interpreting the mechanism of continuous renal replacement therapy in sepsis. The peak concentration hypothesis. Artif Organs 27: 792–801CrossRefPubMedGoogle Scholar
  8. 8.
    Ronco C, Ricci Z, Bellomo R (2002) Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role for CVVH. EDTRA ERCA J 2: 13–18Google Scholar
  9. 9.
    Honore PM, Joannes-Boyau O, Boer W, Gressens B (2007) High volume haemofiltration and hybrid techniques in sepsis: New insights into the rationale. Neth J Crit Care 11: 239–242Google Scholar
  10. 10.
    Honore PM, Joannes-Boyau O, Gressens B (2007) Blood and plasma treatments: the rationale of high-volume hemofiltration. Contrib Nephrol 156: 387–395CrossRefPubMedGoogle Scholar
  11. 11.
    Di Carlo JV, Alexander SR (2005) Hemofiltration for cytokine-driven illness: the mediator delivery hypothesis. Int J Artif Organs 28: 777–786PubMedGoogle Scholar
  12. 12.
    Olszewski WL (2003) The lymphatic system in body homeostasis: physiological conditions. Lymphat Res Biol 1: 11–24CrossRefPubMedGoogle Scholar
  13. 13.
    Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud JJ (2002) Continuous venovenous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Nephrol 15: 150–157PubMedGoogle Scholar
  14. 14.
    Seely AJ, Christou NV (2000) Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 28: 2193–2200CrossRefPubMedGoogle Scholar
  15. 15.
    Mayer J, Rau B, Gansauge F, Beger HG (2000) Inflammatory mediators in human acute pancreatitis: clinical and pathopysiological implications. Gut 47: 542–552Google Scholar
  16. 16.
    Ertel W, Kremer JP, Kenney J, et al (1995) Down regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85: 1341–1347PubMedGoogle Scholar
  17. 17.
    Grootendorst AF, van Bommel EF, van der Hoeven B, van Leengoed LA, van Osta AL (1992) High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18: 235–240CrossRefPubMedGoogle Scholar
  18. 18.
    Grootendorst AF, van Bommel EF, van Leengoed LA, Nabuurs M, Bouman CS, Groeneveld AB (1994) High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 2: 72–78CrossRefPubMedGoogle Scholar
  19. 19.
    Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL (1999) Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 27: 1848–1855CrossRefPubMedGoogle Scholar
  20. 20.
    Honoré PM, Zydney AL, Matson JR (2003) High volume and high permeability haemofiltration in sepsis. The evidences and the key issues. Care Crit Ill 3: 69–76Google Scholar
  21. 21.
    Journois D, Israel-Biet D, Pouard P, et al (1996) High volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 85: 965–976CrossRefPubMedGoogle Scholar
  22. 22.
    Honoré PM, Jamez J, Wauthier M, et al (2000) Prospective evaluation of short term high volume isovolemic haemofiltration on the haemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28: 3581–3587CrossRefPubMedGoogle Scholar
  23. 23.
    Honoré PM, Joannes-Boyau O (2004) High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 27: 1077–1082PubMedGoogle Scholar
  24. 24.
    Matson JR, Zydney RL, Honoré PM (2004) Blood filtration: New opportunities and the implications on system biology. Crit Care Resusc;6: 209–218PubMedGoogle Scholar
  25. 25.
    Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF (1999) Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 25: 814–821CrossRefPubMedGoogle Scholar
  26. 26.
    Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27: 978–986CrossRefPubMedGoogle Scholar
  27. 27.
    Cornejo R, Downey P, Castro R, et al (2006) High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 32: 713–722CrossRefPubMedGoogle Scholar
  28. 28.
    Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G (2004) Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 50: 102–109CrossRefPubMedGoogle Scholar
  29. 29.
    Piccinni P, Dan M, Barbacini S, et al (2006) Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 32: 80–86CrossRefPubMedGoogle Scholar
  30. 30.
    Ratanarat R, Brendolan A, Piccinni P, et al (2005) Pulse-high volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 9: 294–302CrossRefGoogle Scholar
  31. 31.
    Bouman CS, Oudemans-Van-Straaten HM, Tijssen JG, Zandstra DF, Kosecioglu J (2002) Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30: 2205–2211CrossRefPubMedGoogle Scholar
  32. 32.
    Wang H, Zhang ZH, Yan XW, et al (2005)Amelioration of haemodynamics an oxygen metabolism by continuous veno venous hemofiltration in experimental pancreatitis. Word J Gastroenterol 11: 127–131Google Scholar
  33. 33.
    Wang H, Li WQ, Zhou W, Li N, Li JS (2003) Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol 9: 2096–2099PubMedGoogle Scholar
  34. 34.
    Jiang HL, Xhue WJ, Li DK, et al (2005) Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 11: 4815–4821PubMedGoogle Scholar
  35. 35.
    Palevsky PM, Zhang JH, O’Connor TZ, et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7–20CrossRefPubMedGoogle Scholar
  36. 36.
    Ronco C, Honore PM (2008) Renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 1959CrossRefPubMedGoogle Scholar
  37. 37.
    Ronco C, Cruz D, Oudemans-van-Straaten HM, Honoré PM, House A, Bin D, Gibney N (2008) Dialysis dose in acute kidney injury: no time for therapeutic nihilism-a critical appraisal of the Acute Renal Failure Trial Network study. Crit Care 12: 308CrossRefPubMedGoogle Scholar
  38. 38.
    Li CM, Chen JH, Zhang P, et al (2007) Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock. Anaesth Intensive Care 35: 911–919PubMedGoogle Scholar
  39. 39.
    Mandolfo S, Galli F, Costa S, Ravani P, Gaggia P, Imbasciati E (2001) Factors influencing permanent catheter performance. J Vasc Access 2: 106–109PubMedGoogle Scholar
  40. 40.
    Ricci Z, Ronco C (2005) Pre-versus post-dilution CVVH. Blood Purif 23: 338–342CrossRefPubMedGoogle Scholar
  41. 41.
    Nurmohamed SA, Vervloet MG, Girbes AR, Ter Wee PM, Groeneveld AB (2007) Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study. Blood Purif 25: 316–323CrossRefPubMedGoogle Scholar
  42. 42.
    Ratanarat R, Cazzavillan S, Ricci Z, et al (2007) Usefulness of a molecular strategy for the detection of bacterial DNA in patients with severe sepsis undergoing continuous renal replacement therapy. Blood Purif 25: 106–111CrossRefPubMedGoogle Scholar
  43. 43.
    Arzuaga A, Isla A, Gascon AR, Maynar J, Corral E, Pedraz JL (2006) Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: evaluation of the sieving coefficient. Blood Purif 24: 347–354CrossRefPubMedGoogle Scholar
  44. 44.
    Kooman JP, van der Sande FM, Beerenhout CM, Leunissen KM (2006) On-line filtration therapies: emerging horizons. Blood Purif 24: 159–162CrossRefPubMedGoogle Scholar
  45. 45.
    Bellomo R, Honoré PM, Matson JR, Ronco C, Winchester J (2005) Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis. Consensus statement. Position paper. ADQI III Conference. Int J Artif Organs 28: 450–458PubMedGoogle Scholar
  46. 46.
    Bellomo R, Kellum JA, Mehta R, Ronco C (2002) The Acute Dialysis Quality Initiative II: the Vicenza conference. Adv Ren Replace Ther 9 290–293CrossRefPubMedGoogle Scholar
  47. 47.
    Tetta C, Bellomo R, Kellum J, et al (2004) High volume hemofiltration in critically ill patients: why, when and how? Contrib Nephrol 144: 362–375CrossRefPubMedGoogle Scholar
  48. 48.
    Honore PM, Joannes-Boyau O, Gressens B (2007) Blood and plasma treatments: High-volume hemofiltration — A global view. Contrib Nephrol 156: 371–386CrossRefPubMedGoogle Scholar
  49. 49.
    Honore PM, Joannes-Boyau O, Meurson L, et al (2006) The Big Bang of haemofiltration: the beginning of a new era in the third Millennium for extra-corporeal blood purification! Int J Artif Organs 2006 29: 649–659Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • P. M. Honoré
    • 1
  • O. Joannes-Boyau
    • 2
  • W. Boer
    • 3
  1. 1.Department of Intensive CareSt-Pierre Para-Universitary HospitalLouvain-la-NeuveBelgium
  2. 2.Department of Anesthesia and Intensive Care IIUniversity of Bordeaux IIPessacFrance
  3. 3.Department of NephrologyAtrium Medical CenterHeerlenNetherlands

Personalised recommendations